STOCK TITAN

Arteris, Inc. SEC Filings

AIP NASDAQ

Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reading Arteris, Inc.'s SEC filings can feel like navigating a dense wiring diagram—hundreds of pages on deferred royalties, automotive safety certifications, and stock-based compensation. If you need the revenue backlog buried in a 10-K or want to spot Form 4 trades before the next design-win press release, the traditional EDGAR search simply takes too long.

Stock Titan solves this problem. Our AI-powered summaries translate complex semiconductor accounting into plain language, flagging key metrics such as licensing revenue mix, R&D capitalization trends, and customer concentration. Real-time alerts pull every Arteris quarterly earnings report 10-Q filing, 8-K material events explained in minutes, and Arteris insider trading Form 4 transactions as they post—so you never miss a disclosure.

Here’s what you can uncover instantly:

  • Arteris annual report 10-K simplified—royalty schedules, risk factors, and segment performance distilled within seconds.
  • Arteris Form 4 insider transactions real-time—track executive stock sales or option exercises alongside AI context on upcoming product milestones.
  • Proxy statement executive compensation—see how design-win milestones affect equity awards without combing through tables.
  • Arteris earnings report filing analysis—compare quarter-over-quarter gross margin shifts and R&D intensity.

Whether you’re monitoring executive stock transactions, assessing patent litigation exposure, or just trying to understand Arteris SEC filings explained simply, our platform surfaces the data professionals rely on—no jargon, no delays.

Rhea-AI Summary

Arteris, Inc. (AIP) Form 4 filing: 10% owner Bayview Legacy, LLC, managed by CEO K. Charles Janac, reported the sale of 50,000 common shares on 08/05/2025. The trade, executed under a Rule 10b5-1 plan adopted 03/05/2025, was coded “S” (open-market sale). Weighted-average price: $13.1199, with individual transactions between $12.35 and $14.20.

Following the sale, Bayview Legacy’s indirect beneficial ownership stands at 9,839,071 shares. No derivative transactions were reported. Janac has filed a separate Form 4 reflecting the same activity due to his control of the LLC.

The disposition represents roughly 0.5% of Bayview Legacy’s post-transaction holdings, leaving the insider with a substantial stake and signaling limited portfolio rebalancing rather than a material exit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
quarterly report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
37.57%
Tags
other

FAQ

What is the current stock price of Arteris (AIP)?

The current stock price of Arteris (AIP) is $9.97 as of August 22, 2025.

What is the market cap of Arteris (AIP)?

The market cap of Arteris (AIP) is approximately 383.0M.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Stock Data

383.00M
29.50M
30.79%
47.8%
2.57%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL